View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Dispatch R883 an mTORC1 substrate that negatively regulates inhibitors. Oncogene http://dx.doi.org/10.1038/ 1Department of Cancer and Cell Biology, insulin signaling. Science 332, 1322–1326. onc.2013.92. University of Cincinnati College of Medicine, 16. Chung, J., Kuo, C.J., Crabtree, G.R., and 19. She, Q.B., Halilovic, E., Ye, Q., Zhen, W., Cincinnati, OH 45267, USA. 2Institute for Blenis, J. (1992). Rapamycin-FKBP specifically Shirasawa, S., Sasazuki, T., Solit, D.B., and blocks growth-dependent activation of and Rosen, N. (2010). 4E-BP1 is a key effector of the Research in Immunology and Cancer (IRIC), signaling by the 70 kd S6 protein kinases. Cell oncogenic activation of the AKT and ERK Universite´ de Montre´ al, Montreal, 69, 1227–1236. signaling pathways that integrates their Quebec H3C 3J7, Canada. 3Department of 17. Zhang, Y., and Zheng, X.F. (2012). function in tumors. Cancer Cell 18, Pathology and Cell Biology, Faculty of mTOR-independent 4E-BP1 phosphorylation is 39–51. Medicine, Universite´ de Montre´ al, Montreal, associated with cancer resistance to mTOR 20. Shin, S., Wolgamott, L., Tcherkezian, J., kinase inhibitors. Cell Cycle 11, 594–603. Vallabhapurapu, S., Yu, Y., Roux, P.P., and Quebec, H3C 3J7, Canada. 18. Ducker, G.S., Atreya, C.E., Simko, J.P., Yoon, S.O. (2013). Glycogen synthase E-mail:
[email protected], philippe. Hom, Y.K., Matli, M.R., Benes, C.H., Hann, B., kinase-3beta positively regulates protein
[email protected] Nakakura, E.K., Bergsland, E.K., Donner, D.B., synthesis and cell proliferation through the et al.